These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 8912956

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride.
    Hirvonen J, Aalto S, Lumme V, Någren K, Kajander J, Vilkman H, Hagelberg N, Oikonen V, Hietala J.
    Nucl Med Commun; 2003 Dec; 24(12):1207-14. PubMed ID: 14627846
    [Abstract] [Full Text] [Related]

  • 4. Dopamine D2 and D3 receptor occupancy in normal humans treated with the antipsychotic drug aripiprazole (OPC 14597): a study using positron emission tomography and [11C]raclopride.
    Yokoi F, Gründer G, Biziere K, Stephane M, Dogan AS, Dannals RF, Ravert H, Suri A, Bramer S, Wong DF.
    Neuropsychopharmacology; 2002 Aug; 27(2):248-59. PubMed ID: 12093598
    [Abstract] [Full Text] [Related]

  • 5. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients.
    Farde L, Suhara T, Nyberg S, Karlsson P, Nakashima Y, Hietala J, Halldin C.
    Psychopharmacology (Berl); 1997 Oct; 133(4):396-404. PubMed ID: 9372541
    [Abstract] [Full Text] [Related]

  • 6. N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic.
    Hagberg G, Gefvert O, Bergström M, Wieselgren IM, Lindström L, Wiesel FA, Långström B.
    Psychiatry Res; 1998 Jun 30; 82(3):147-60. PubMed ID: 9754439
    [Abstract] [Full Text] [Related]

  • 7. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.
    Kapur S, Zipursky R, Remington G, Jones C, McKay G, Houle S.
    Am J Psychiatry; 1997 Nov 30; 154(11):1525-9. PubMed ID: 9356559
    [Abstract] [Full Text] [Related]

  • 8. Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D2 blockade.
    Fitzgerald PB, Kapur S, Caligiuri MP, Jones C, Silvestri S, Remington G, Zipursky RB.
    Neuropsychopharmacology; 2000 Jan 30; 22(1):19-26. PubMed ID: 10633487
    [Abstract] [Full Text] [Related]

  • 9. Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis.
    Zipursky RB, Christensen BK, Daskalakis Z, Epstein I, Roy P, Furimsky I, Sanger T, Kapur S.
    Can J Psychiatry; 2005 Jul 30; 50(8):462-9. PubMed ID: 16127964
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study.
    Kapur S, Remington G, Jones C, Wilson A, DaSilva J, Houle S, Zipursky R.
    Am J Psychiatry; 1996 Jul 30; 153(7):948-50. PubMed ID: 8659621
    [Abstract] [Full Text] [Related]

  • 16. Within-subject comparison of striatal D2 receptor occupancy measurements using [123I]IBZM SPECT and [11C]Raclopride PET.
    Catafau AM, Suarez M, Bullich S, Llop J, Nucci G, Gunn RN, Brittain C, Laruelle M, Barcelona Clinical Imaging in Psychiatry Group.
    Neuroimage; 2009 Jun 30; 46(2):447-58. PubMed ID: 19233294
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of methods for analysis of clinical [11C]raclopride studies.
    Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, Frackowiak RS.
    J Cereb Blood Flow Metab; 1996 Jan 30; 16(1):42-52. PubMed ID: 8530554
    [Abstract] [Full Text] [Related]

  • 19. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.
    Kapur S, Zipursky R, Jones C, Remington G, Houle S.
    Am J Psychiatry; 2000 Apr 30; 157(4):514-20. PubMed ID: 10739409
    [Abstract] [Full Text] [Related]

  • 20. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients.
    Nordström AL, Farde L, Wiesel FA, Forslund K, Pauli S, Halldin C, Uppfeldt G.
    Biol Psychiatry; 1993 Feb 15; 33(4):227-35. PubMed ID: 8097114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.